QVAR Delivers Asthma Medication to More of Your Lungs' Airways

QVAR®, a Long-Term Control Inhaler for Asthma

Small-particle inhaled corticosteroid (ICS) for everyday use

QVAR® is a small-particle ICS, which means the medicine can reach small airways in your lungs.1 This means QVAR® can get to more of the airways in your lungs to treat the inflammation that is a key underlying cause of asthma.

There are specific instructions for cleaning and using the QVAR® inhaler that can help ensure the inhaler works right. Forgetting to take your asthma control medication every day, or stopping when you don't have symptoms, can put you at risk for asthma attacks. And remember, if you have persistent asthma, you should always carry a quick-relief inhaler in addition to your controller medication.

*The relationship of lung deposition and particle size to clinical efficacy is unknown.

Approved Uses


QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol is used in the ongoing treatment of asthma as preventative therapy in patients 5 years of age or older.

QVAR® is also used for asthma patients who require systemic corticosteroid administration, where adding QVAR® may reduce or eliminate the need for systemic corticosteroids.

Important Safety Information


QVAR® does not replace quick-relief inhalers for sudden symptoms.

CAUTION: If you are stopping or switching from an oral corticosteroid to QVAR®, follow your doctor's instructions to avoid health risks. (See WARNINGS, Prescribing Information).

Inhaled corticosteroids may cause a reduction in growth rate, so children taking QVAR® should have their growth checked regularly. The long-term effect on final adult growth is unknown.

Do not stop taking QVAR® abruptly without talking to your doctor.

In clinical studies, common side effects included headache and sore throat. These are not all of the possible side effects of QVAR®. For more information, ask your healthcare provider or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.



Reference
  1. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002;122:510-516.
121527